Abstract:Intrauterine hyperglycemia of gestational diabetes mellitus (GDM) leads to long-term metabolic dysfunction in generations. Previous studies include both intrauterine exposure and postnatal adult diabetic conditions as influence factors. The aim of our study is to assess the impact of intrauterine hyperglycemia per se on F2 generation's metabolism via germ cells. Animal model study. A streptozotocin-induced GDM mouse model was established. Only male individuals were studied. Healthy F1-GDM male mice were crossed with normal female to produce F2 generation. Body weight, glucose tolerance test (GTT), insulin tolerance test (ITT), serum fasting insulin and lipids parameters were determined at 8 week in both generations, homeostasis model of insulin resistance (HOMA-IR) index was then calculated. Reduced Representation Bisulfite Sequencing (RRBS) was performed on primordial germ cells (PGCs) of E13.5 male F1-GDM and control fetus. Ingenuity Pathway Analysis (IPA) was used to identify the top related physiological pathways. Comparisons between two groups were performed using Student t-tests. One-way ANOVA was used to compare differences among multiple groups. For each group, n>10. A P<0.05 was considered statistically significant. (1) F1-GDM male mice which showed no significant difference in body weight, GTT, ITT, HOMA-IR index and serum parameters with control mice (P>0.05), were chosen as healthy founders to produce F2 generation. (2) Some of F2-GDM offspring (28/41) exhibited glucose intolerance (P<0.001). (3) All the F2-GDM offspring exhibited higher ITT curve than control (P<0.001 of normal glucose tolerance individuals, P<0.05 of glucose intolerance individuals, vs. control). All the F2-GDM offspring exhibited higher HOMA-IR index (P<0.01 of normal glucose tolerance individuals vs. control, P<0.05 of glucose intolerance individuals vs. control). (4) F2-GDM offspring had higher body weight than control mice (P<0.001 of normal glucose tolerance individuals, P<0.001 of glucose intolerance individuals, vs. control). (5) Glucose intolerance F2 mice showed higher triacylglycerol and non-esterified fatty acid than control (P<0.05). (6) RRBS revealed 1842 differentially methylated genes. These genes were mainly involved in cell cycle, HGF signaling, ERK/MAPK signaling, insulin receptor signaling and PI3K/AKT signaling pathways. Intrauterine hyperglycemia exposure per se contributes to glycolipid metabolism dysfunction in F2 generation. The aberrant methylation erasure in PGCs may provide one possible epigenetic mechanism underlies the transmission effect.

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Methylation Levels at Igf2 and Gnas Dmrs in Infants Born to Preeclamptic Pregnancies

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Placental Delta-Like 1 Gene DNA Methylation Levels Are Related to Mothers’ Blood Glucose Concentration

Prenatal Gestational Diabetes Mellitus Exposure and Accelerated Offspring DNA Methylation Age in Early Childhood.

Intrauterine Hyperglycemia Altered Imprinted Genes Expression in Germ Cells of Male Offspring.

Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children.

Intrauterine Hyperglycemia Exposure Per Se Affects Glycolipid Metabolism in Second Generation Via Epigenetic Modification on Germ Cells.

Maternal glycemia in pregnancy is longitudinally associated with blood DNAm variation at the FSD1L gene from birth to 5 years of age

Association of Methylation-Related Nutrient Intake and Status with Offspring DNA Methylation in Pregnant Women with and Without Gestational Diabetes Mellitus

Intrauterine Hyperglycemia Exposure Results in Intergenerational Inheritance Via DNA Methylation Reprogramming on F1 PGCs

Insulin Therapy of Gestational Diabetes Does Not Fully Protect Offspring from Diet-Induced Metabolic Disorders.

Study on the relationship between DNA methylation of target CpG sites in peripheral blood and gestational diabetes during early pregnancy

Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood

Placental DNA methylation changes in gestational diabetes mellitus

Associations between nutrients in one-carbon metabolism and fetal DNA methylation in pregnancies with or without gestational diabetes mellitus

Associations of maternal early-pregnancy blood glucose and insulin concentrations with DNA methylation in newborns

Alteration in Methylation Level at Differential Methylated Regions of MEST and DLK1 in Fetus of Preeclampsia.

Intergenerational Transmission of Glucose Intolerance Associated with Gestational Diabetes Mellitus

Deciphering DNA Methylation in Gestational Diabetes Mellitus: Epigenetic Regulation and Potential Clinical Applications